Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
2,950.00
2,622.00
2,177.00
1,852.00
1,490.00
1,376.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,950.00
2,622.00
2,177.00
1,852.00
1,490.00
1,376.00
Expenditure (Ex Depriciation)
Stock Adjustments
-136.00
-183.00
-73.00
-6.00
12.00
-136.00
Raw Materials Consumed
1,413.00
1,327.00
1,111.00
927.00
703.00
731.00
Power & Fuel Cost
54.00
40.00
36.00
24.00
18.00
16.00
Employee Cost
420.00
350.00
293.00
239.00
220.00
197.00
Operating Expenses
155.00
140.00
87.00
18.00
12.00
34.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
260.00
256.00
127.00
102.00
119.00
109.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
71.00
41.00
26.00
164.00
115.00
39.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,350.00
2,090.00
1,718.00
1,512.00
1,231.00
1,036.00
Operating Profit (PBDIT) excl Other Income
600.00
532.00
458.00
339.00
258.00
339.00
Other Income
82.00
66.00
50.00
59.00
41.00
6.00
Operating Profit (PBDIT)
683.00
599.00
508.00
398.00
300.00
346.00
Interest
24.00
11.00
11.00
9.00
8.00
7.00
Profit before Depriciation and Tax
659.00
587.00
497.00
389.00
292.00
338.00
Depreciation
98.00
83.00
74.00
51.00
44.00
36.00
Profit Before Taxation & Exceptional Items
560.00
503.00
423.00
337.00
247.00
302.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
560.00
503.00
423.00
337.00
247.00
302.00
Provision for Tax
140.00
121.00
108.00
72.00
60.00
63.00
Profit After Tax
420.00
382.00
314.00
265.00
186.00
238.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,422.00
1,068.00
777.00
509.00
334.00
85.00
Profit Available for appropriations
1,839.00
1,449.00
1,091.00
775.00
519.00
321.00
Appropriations
1,839.00
1,449.00
1,091.00
775.00
519.00
321.00
Equity Dividend (%)
90.00%
80.00%
60.00%
50.00%
25.00%
25.00%
Earnings Per Share
9.22
8.40
6.92
6.41
4.51
5.76
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 12.51% vs 20.46% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 12.78% vs 16.16% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 106.90% vs 4.08% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 9.79% vs 21.51% in Mar 2025
Compare Profit and Loss Results of Marksans Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,950.00
1,196.00
1,754.00
146.66%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,950.00
1,196.00
1,754.00
146.66%
Expenditure (Ex Depriciation)
Stock Adjustments
-136.00
-23.00
-113.00
-491.30%
Raw Materials Consumed
1,413.00
260.00
1,153.00
443.46%
Power & Fuel Cost
54.00
6.00
48.00
800.00%
Employee Cost
420.00
346.00
74.00
21.39%
Operating Expenses
155.00
6.00
149.00
2,483.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
260.00
111.00
149.00
134.23%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
71.00
59.00
12.00
20.34%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,350.00
956.00
1,394.00
145.82%
Operating Profit (PBDIT) excl Other Income
600.00
239.00
361.00
151.05%
Other Income
82.00
5.00
77.00
1,540.00%
Operating Profit (PBDIT)
683.00
245.00
438.00
178.78%
Interest
24.00
10.00
14.00
140.00%
Profit before Depriciation and Tax
659.00
235.00
424.00
180.43%
Depreciation
98.00
37.00
61.00
164.86%
Profit Before Taxation & Exceptional Items
560.00
198.00
362.00
182.83%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
560.00
198.00
362.00
182.83%
Provision for Tax
140.00
49.00
91.00
185.71%
Profit After Tax
420.00
149.00
271.00
181.88%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,422.00
377.00
1,045.00
277.19%
Profit Available for appropriations
1,839.00
527.00
1,312.00
248.96%
Appropriations
1,839.00
527.00
1,312.00
248.96%
Equity Dividend (%)
90%
73.1%
16.90
Earnings Per Share
9.22
24.43
-15.21
-62.26%
Profit And Loss - Net Sales
Net Sales 2,950.94 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.51% vs 20.46% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 600.78 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.78% vs 16.16% in Mar 2025
Profit And Loss - Interest
Interest 24.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 106.90% vs 4.08% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 420.06 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.79% vs 21.51% in Mar 2025






